For instance, Loi et al. used gene expression profiles from primary breast tumors containing PIK3CA mutations to design a signature of PI3K activation to predict PI3K-Akt-mTOR pathway activity in an independent dataset [12]. This evidence concerns the gene PIK3CA and breast neoplasm.